Kala Bio KALA
NASDAQ KALA
$0.82 -0.02 (-2.39%)
As of: Aug 21, 2026 · 3:58 PM EDT

Kala Bio (KALA) Other Operating Expenses (2016 - 2025)

Kala Bio (KALA) posted Other Operating Expenses of -$3.4 million for Q3 2025, down 2336.6% sequentially from $153000.0 in Q2 2025, and down 914.76% YoY from $420000.0 in Q3 2024.

Kala Bio (KALA) Other Operating Expenses (2016 - 2025) Analysis & Trends

Kala Bio has reported Other Operating Expenses for 10 years, with the latest figure at -$3.4 million in Q3 2025.

  • Quarterly Other Operating Expenses fell 914.76% year-over-year to -$3.4 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (down 893.45% YoY) and the FY2025 annual result came in at -$3.2 million, down 691.62% from the prior year.
  • Other Operating Expenses declined to -$3.4 million in Q3 2025 per KALA's latest filing, from $153000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $47.0 million in Q3 2022 and troughed at -$7.5 million in Q2 2021.
  • A 5-year average of $1.7 million and a median of -$29000.0 in 2024 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2022 and 2025: Other Operating Expenses surged 2385.75% in 2022, then tumbled 914.76% in 2025.
  • Over 5 years, Other Operating Expenses stood at -$753000.0 in 2021, then soared by 6341.04% to $47.0 million in 2022, then sank by 99.41% to $278000.0 in 2023, then jumped by 51.08% to $420000.0 in 2024, then sank by 914.76% to -$3.4 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered -$3.4 million, $153000.0, and $21000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Kala Bio 9.89 Mn 9.89 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -3.42 Mn
Jun 30, 2025 153,000.00
Mar 31, 2025 21,000.00
Sep 30, 2024 420,000.00
Jun 30, 2024 -29,000.00
Mar 31, 2024 158,000.00
Dec 31, 2023 278,000.00
Sep 30, 2023 -1.74 Mn
Jun 30, 2023 359,000.00
Mar 31, 2023 1.62 Mn
Sep 30, 2022 47.00 Mn
Jun 30, 2022 -2.14 Mn
Mar 31, 2022 -2.03 Mn
Dec 31, 2021 -753,000.00
Sep 30, 2021 -2.06 Mn
Jun 30, 2021 -7.45 Mn
Mar 31, 2021 -2.10 Mn
Dec 31, 2020 -2.13 Mn
Sep 30, 2020 -2.11 Mn
Jun 30, 2020 -2.03 Mn